Use of Extracorporeal Membrane Oxygenation (ECMO) in the Management of Acute Respiratory Distress Syndrome (ARDS) in Critically Ill Patients.

EasyChair Preprint 9813

Abstract

Acute respiratory distress syndrome (ARDS) is a severe and often fatal condition, with a high mortality rate despite advances in critical care management. Extracorporeal membrane oxygenation (ECMO) is a technique that provides respiratory and/or circulatory support to critically ill patients who have failed conventional management. The purpose of this literature review is to examine the current evidence regarding the use of ECMO in the management of ARDS in critically ill patients. A systematic search of PubMed, MEDLINE, and Cochrane Library databases was performed for relevant articles published between 2010 and 2022. A total of 45 articles were identified, of which 22 met the inclusion criteria for this review. The articles included both retrospective and prospective studies, case reports, and systematic reviews. The current evidence suggests that ECMO can be an effective treatment for ARDS in critically ill patients, and its use has been associated with improved survival rates. However, the optimal timing of ECMO initiation remains unclear, and there are several complications associated with its use. Further studies are needed to determine the best practices for ECMO use in ARDS patients, including optimal patient selection, timing of initiation, and management of associated complications.

Keyphrases: Acute Respiratory Distress Syndrome, Critical Care, ECMO, Mortality, extracorporeal membrane oxygenation

@booklet{EasyChair:9813,
  author    = {Abdullah Al-Murad},
  title     = {Use of Extracorporeal Membrane Oxygenation (ECMO) in the Management of Acute Respiratory Distress Syndrome (ARDS) in Critically Ill Patients.},
  howpublished = {EasyChair Preprint 9813},
  year      = {EasyChair, 2023}}